These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38906860)

  • 1. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.
    Huang SY; Gong S; Zhao Y; Ye ML; Li JY; He QM; Qiao H; Tan XR; Wang JY; Liang YL; Huang SW; He SW; Li YQ; Xu S; Li YQ; Liu N
    Nat Commun; 2024 Jun; 15(1):5300. PubMed ID: 38906860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DCAF7 Acts as A Scaffold to Recruit USP10 for G3BP1 Deubiquitylation and Facilitates Chemoresistance and Metastasis in Nasopharyngeal Carcinoma.
    Li QJ; Fang XL; Li YQ; Lin JY; Huang CL; He SW; Huang SY; Li JY; Gong S; Liu N; Ma J; Zhao Y; Tang LL
    Adv Sci (Weinh); 2024 Sep; 11(36):e2403262. PubMed ID: 38973296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobaplatin induces pyroptosis through regulating cIAP1/2, Ripoptosome and ROS in nasopharyngeal carcinoma.
    Chen Z; Xu G; Wu D; Wu S; Gong L; Li Z; Luo G; Hu J; Chen J; Huang X; Chen C; Jiang Z; Li X
    Biochem Pharmacol; 2020 Jul; 177():114023. PubMed ID: 32413426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 5. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.
    Xie L; Shi F; Li Y; Li W; Yu X; Zhao L; Zhou M; Hu J; Luo X; Tang M; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Signal Transduct Target Ther; 2020 May; 5(1):56. PubMed ID: 32433544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein.
    Chen KL; Huang SW; Yao JJ; He SW; Gong S; Tan XR; Liang YL; Li JY; Huang SY; Li YQ; Zhao Y; Qiao H; Xu S; Zang S; Ma J; Liu N
    Drug Resist Updat; 2024 Sep; 76():101111. PubMed ID: 38908233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    Xia T; Tian H; Zhang K; Zhang S; Chen W; Shi S; You Y
    BMC Cancer; 2021 Sep; 21(1):1003. PubMed ID: 34493236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinoma.
    Takamizawa S; Honma Y; Murakami N; Mori T; Oka H; Yamamoto S; Kashihara T; Ito K; Kubo Y; Ikeda A; Matsumoto F; Omura G; Kobayashi K; Itami J; Kato K; Yoshimoto S
    Invest New Drugs; 2021 Apr; 39(2):564-570. PubMed ID: 32940872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIX-01294-enhanced chemosensitivity in nasopharyngeal carcinoma depends on autophagy-induced pyroptosis.
    Li Q; Wang M; Zhang Y; Wang L; Yu W; Bao X; Zhang B; Xiang Y; Deng A
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1131-1139. PubMed ID: 33085742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1.
    Hong X; Liu N; Liang Y; He Q; Yang X; Lei Y; Zhang P; Zhao Y; He S; Wang Y; Li J; Li Q; Ma J; Li Y
    Mol Cancer; 2020 Feb; 19(1):33. PubMed ID: 32061262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients.
    Cheng J; Qian D; Ding X; Song T; Cai M; Dan Xie ; Wang Y; Zhao J; Liu Z; Wu Z; Pang Q; Zhu L; Wang P; Hao X; Yuan Z
    Cell Death Dis; 2018 Sep; 9(10):991. PubMed ID: 30250224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor ATMIN facilitates chemoresistance in nasopharyngeal carcinoma.
    Fang XL; Li QJ; Lin JY; Huang CL; Huang SY; Tan XR; He SW; Zhu XH; Li JY; Gong S; Qiao H; Li YQ; Liu N; Ma J; Zhao Y; Tang LL
    Cell Death Dis; 2024 Feb; 15(2):112. PubMed ID: 38321024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.
    Yu X; Wang R; Zhang Y; Zhou L; Wang W; Liu H; Li W
    Oncogene; 2019 Dec; 38(50):7457-7472. PubMed ID: 31435020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
    Zhu Y; Hu Q; Li H
    Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAT10 inhibition promotes ac4C-dependent ferroptosis to counteract sorafenib resistance in nasopharyngeal carcinoma.
    Xue Z; Xie H; Shan Y; Zhang L; Cheng L; Chen W; Zhu R; Zhang K; Ni H; Zhang Z; You Y; You B
    Cancer Sci; 2024 Oct; 115(10):3256-3272. PubMed ID: 39038928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitor TW-37 is tolerable and synergistic with chemotherapy in nasopharyngeal carcinoma.
    Lu Y; Huang H; Yang H; Chen D; Wu S; Jiang Z; Wang R
    Cell Cycle; 2017 Jul; 16(14):1376-1383. PubMed ID: 28696828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-2110 induced by chemically synthesized cinobufagin functions as a tumor-metastatic suppressor via targeting FGFR1 to reduce PTEN ubiquitination degradation in nasopharyngeal carcinoma.
    Fang S; Peng L; Zhang M; Hou R; Deng X; Li X; Xin J; Peng L; Liu Z; Liu Y; Xie Y; Zhou B; Fang W; Liu Z; Cheng C
    Environ Toxicol; 2024 Jun; 39(6):3548-3562. PubMed ID: 38477013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma.
    Chen Y; Zhao Y; Yang X; Ren X; Huang S; Gong S; Tan X; Li J; He S; Li Y; Hong X; Li Q; Ding C; Fang X; Ma J; Liu N
    Nat Commun; 2022 Jan; 13(1):501. PubMed ID: 35079021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
    Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of docetaxel, cisplatin and fluorouracil (TPF)-based induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
    Zhou R; Zhu J; Chen X; Liu Y; Wang Y; Zhang T
    Clin Transl Oncol; 2020 Mar; 22(3):429-439. PubMed ID: 31165410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.